£108.78

About as cheap as it gets — within 5% of the all-time low it hit 2 months ago.

£109 today · all-time low £107 (Sep 2026) · usually £109

Springer Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£113.77 £105.86 £107.59 £109.31 £111.04 £112.76 £114.49 22 August 2026 06 September 2026 21 September 2026 06 October 2026 22 October 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 3 price levels

Days at Price
Current Price
17 days 24 days · current 21 days 0 6 12 18 24 £107 £109 £114 Days at Price

Price Analysis

Most common price: £109 (24 days, 38.7%)

Price range: £107 - £114

Price levels: 3 different prices over 62 days

Description

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities. The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series)
86% match

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series)

Springer

£86.15 24 Oct 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
84% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£113.69 24 Oct 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
84% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£75.96 24 Oct 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
84% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£112.59 28 Oct 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
83% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£148.19 21 Oct 2026
Bispecific Antibodies
83% match

Bispecific Antibodies

Springer

£129.06 29 Oct 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
82% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£114.89 23 Oct 2026
Conjugation―Deconjugation Reactions in Drug Metabolism and Toxicity: 112 (Handbook of Experimental Pharmacology, 112)
82% match

Conjugation―Deconjugation Reactions in Drug Metabolism and Toxicity: 112 (Handbook of Experimental Pharmacology, 112)

Springer

£77.49 12 Sep 2026
Molecular Imaging for Integrated Medical Therapy and Drug Development
82% match

Molecular Imaging for Integrated Medical Therapy and Drug Development

Springer

£113.93 21 Oct 2026
Pharmacology of Immunotherapeutic Drugs
82% match

Pharmacology of Immunotherapeutic Drugs

Springer

£73.14 22 Oct 2026
Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects, VIII)
82% match

Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects, VIII)

Springer

£110.73 22 Oct 2026
Immunodiagnostic Technologies from Laboratory to Point-Of-Care Testing
82% match

Immunodiagnostic Technologies from Laboratory to Point-Of-Care Testing

Springer

£108.00 12 Sep 2026
Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)
82% match

Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)

Humana

£69.37 22 Oct 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
82% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£137.86 21 Oct 2026
Antibodies: Volume 1: Production and Purification
82% match

Antibodies: Volume 1: Production and Purification

Springer

£110.54 24 Oct 2026
Immunopharmacology: Principles and Perspectives
82% match

Immunopharmacology: Principles and Perspectives

Springer

£77.90 28 Oct 2026
Drugs Targeting B-Cells in Autoimmune Diseases (Milestones in Drug Therapy)
81% match

Drugs Targeting B-Cells in Autoimmune Diseases (Milestones in Drug Therapy)

Springer

£114.06 27 Oct 2026
Stem Cell Drugs - A New Generation of Biopharmaceuticals (Stem Cells in Clinical Applications)
81% match

Stem Cell Drugs - A New Generation of Biopharmaceuticals (Stem Cells in Clinical Applications)

Springer

£74.77 27 Oct 2026
Enzyme-Prodrug Strategies for Cancer Therapy
81% match

Enzyme-Prodrug Strategies for Cancer Therapy

Springer

£149.87 23 Oct 2026
Development of Antibody-Based Therapeutics: Translational Considerations & Challenges
81% match

Development of Antibody-Based Therapeutics: Translational Considerations & Challenges

Adis

£111.83 24 Oct 2026
Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds
81% match

Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds

Springer

£114.71 26 Oct 2026
Gene Therapy of Autoimmune Disease (Medical Intelligence Unit)
81% match

Gene Therapy of Autoimmune Disease (Medical Intelligence Unit)

Springer

£108.33 22 Oct 2026
Targeted Interference with Signal Transduction Events: 172 (Recent Results in Cancer Research, 172)
81% match

Targeted Interference with Signal Transduction Events: 172 (Recent Results in Cancer Research, 172)

Springer

£87.78 12 Sep 2026
Advanced Targeting of the Lymphatic System
81% match

Advanced Targeting of the Lymphatic System

Springer

£128.48 27 Oct 2026